[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.129.96. Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Citations 0
Correction
June 13, 2001

Wording and Level Errors

JAMA. 2001;285(22):2858. doi:10.1001/jama.285.22.2858

In the Original Contribution entitled "Abacavir-Lamivudine-Zidovudine vs Indinavir-Lamivudine-Zidovudine in Antiretroviral-Naive HIV-Infected Adults: A Randomized Equivalence Trial" published in the March 7, 2001, issue of THE JOURNAL (2001;285:1155-1163), wording and level errors appeared. On page 1158, the last sentence in the first paragraph in column 3 should be: "In the as-treated analysis, the proportion of patients who had HIV RNA levels of 50 copies/mL or less was greater in the indinavir-lamivudine-zidovudine group for both strata: 76% (74/97) vs 88% (76/86) with a treatment difference of − 12% (95% CI, − 23% to − 1%) for the low baseline HIV RNA stratum and 57% (30/53) vs 74% (45/61) with a treatment difference of − 17% (95% CI, − 34% to 0%) for the high baseline HIV RNA stratum." On page 1162, the last sentence in the first full paragraph should be: "The difficulty in achieving an undetectable viral load among patients with high baseline HIV-1 RNA levels supports the need to initiate antiretroviral treatment in a manner consistent with treatment guidelines.1,2"

×